VisMederi Holding

Improving human health

VISMEDERI TEXTYLE SRL

Qualified Centre capable of carrying out all the main analyses necessary to certify the quality of textile materials, as well as the conformity and quality of raw materials and semi-finished products in the tanning sector with the verification of CITES certificates through DNA analysis.

www.vismederitextyle.com

tttt

tttt

ttt

tttt

tttt

ttt

tttt

tttt

ttt

tttt

tttt

ttt

tttt

tttt

ttt

tttt

tttt

ttt

Vismederi Group

The Group of Vismederi Holding operates in various business areas all related to Research and Innovation in the fields of Public Health, Life Sciences and Biotechnologies and is composed of VisMederi Srl, VisMederi Research Srl, VisMederi Life Sciences Srl, VisMederi Textyle Srl, VisMederi Pharma Srl, ETHS – Education and Training for Health Sciences Srl with single shareholder, Srl.

Vismederi Holding

VisMederi is today a solid reality that grew year after year in credibility, customer portfolio, human resources and economic results. These are the results of prolific work carried out by a motivated, young and highly competent group, which has found in VisMederi not only a job but also a great opportunity for professional growth.

0Mln €

Revenues

0

Employees 

0Paesi

Global Partnerships

Vismederi Holding: last news

All the news of the group

Jan 18 2024

New Research Highlights the Importance of Vaccinations in Leukemia Patients

VisMederi is excited to share a significant breakthrough in medical research conducted in collaboration with Landspítali University of Reykjavík,...
Nov 23 2023

Making Strides in Global Health: VisMederi at the World Bio Summit 2023!

VisMederi, represented by the Founder and CSO Prof. Emanuele Montomoli, played a pivotal role at the esteemed World Bio Summit 2023 in Seoul. This...
Nov 23 2023

VisMederi reaffirms its position as a “Growth Leader”

The Siena-based business ranks second in the "Pharmaceuticals and Biotechnology" category and 84th overall....
Nov 21 2023

GBA Roadshow 2023

Embarking on a journey of growth and opportunity, VisMederi's Chief Financial Officer, Simone Paletti, is participating in the esteemed GBA Roadshow...
Nov 21 2023

Project Leader Silvia Grappi represented VisMederi at the 11th EDTCP meeting in Paris

The biannual EDCTP Forum offered a worldwide venue for the presentation and discussion of clinical research for anybody concerned in the fight...
Oct 25 2023

VisMederi Foundation with “Ragazzi del ‘53” in support of “Le Bollicine” Association

That of the "Ragazzi del '53" is an adventure born in 1953 from the will of some young adults in their 30s who were entering, according to the...
Aug 14 2023

Another remarkable milestone in our journey of scientific collaboration

We're thrilled to share another remarkable milestone in our journey of scientific collaboration. Our latest article,” "Characterization of...
Jul 23 2023

VisMederi Foundation: Continuing its Commitment to Social Welfare by Supporting Piccolo Principe and Danilo Nannini Foundation

The VisMederi Foundation demonstrates its commitment to the most vulnerable groups, strengthening its ties with the Siena territory and actively...
Jul 17 2023

VisMederi Receives Prestigious Certificate from The Coalition for Epidemic Preparedness Innovations (CEPI)

We are delighted to share the exciting news that VisMederi has been honored with a prestigious certificate from The Coalition for Epidemic...
Jul 07 2023

Neutralizing antibody responses against the Respiratory Syncytial Virus

New paper dissecting the neutralizing antibody responses against the Respiratory Syncytial Virus; a new approach to virus neutralization assay...

Where we

are

 

 

 

 

 

 

The

founder

Emanuele Montomoli is Full Professor of Hygiene and Public Health at the University of Siena, Italy. He received his BSc and MSc in Life Sciences from the University of Siena, Italy in 1997 and he earned his MBiochem in 2001.

Comments Box SVG iconsUsed for the like, share, comment, and reaction icons
1 week ago
VisMederi Group

La direttrice della Gazzetta di Siena, Susanna Guarino, ha intervistato Emanuele Montomoli, CSO di VisMederi, offrendo un'interessante prospettiva sulle attività, gli obiettivi e le sfide future dell'azienda.

Nell�Emanuele Montomolinuele Montomoli discute dell'impegno di VisMederi nella ricerca e nell'innovazione nel settore della salute pubblica, oltre a fornire dettagli sui progetti in corso e sulle aspirazioni per il futuro.

Guarda l'intervista qui: : www.youtube.com/live/KXm#vismederii#innovaziones#salutepubblicai#ricercaz#futuroa#biotecnopolo#Ricerca #Futuro
#biotecnopolo
... See MoreSee Less

Video image

0 CommentsComment on Facebook

1 week ago
VisMederi Group

Non perdete l'approfondimento della settimana a cura della Gazzetta di Siena con il CSO di VisMederi, Emanuele Montomoli, in una conversazione esclusiva per la serie ‘Le Voci della Città’.

Un dialogo informativo sulla scienza, la salute pubblica e il futuro della ricerca.

📅 Lunedì alle 22.00 su www.gazzettadisiena.it/

#VisMederi #Salute #Ricerca #Scienza #Innovazione
... See MoreSee Less

Non perdete lapprofondimento della settimana a cura della Gazzetta di Siena  con il CSO di VisMederi, Emanuele Montomoli, in una conversazione esclusiva per la serie ‘Le Voci della Città’.

Un dialogo informativo sulla scienza, la salute pubblica e il futuro della ricerca.

📅 Lunedì alle 22.00 su https://www.gazzettadisiena.it/

#VisMederi #Salute #Ricerca #Scienza #Innovazione
4 weeks ago
VisMederi Group

Our manuscript "#CEPI Centralized Laboratory Network: a qualification analysis" has been published in The Lancet Microbe Online.

This publication marks a significant contribution to the global scientific community, showcasing our latest advancements in vaccine clinical trials.

Read the full manuscript here: www.thelancet.com/journals/lanmic/article/PIIS2666-5247(23)00324-5/fulltext

Furthermore, anticipate the inclusion of our work in the upcoming issue of The Lancet Microbe, set to go live on February 28.

Join us in recognizing this important milestone in scientific research and stay updated for more developments.

#VisMederi #TheLancetMicrobe #VaccineResearch #SARSCoV2 #ScienceInnovation

********

Il nostro manoscritto "CEPI Centralized Laboratory Network: a qualification analysis" è stato pubblicato su The Lancet Microbe Online.

Questa pubblicazione rappresenta un contributo significativo alla comunità scientifica globale, mostrando i nostri ultimi progressi nei trial clinici dei vaccini.

Leggi il manoscritto completo qui: www.thelancet.com/journals/lanmic/article/PIIS2666-5247(23)00324-5/fulltext

#VisMederiGroup #RicercaVaccini #InnovazioneScientifica
... See MoreSee Less

Our manuscript #CEPI Centralized Laboratory Network: a qualification analysis has been published in The Lancet Microbe Online.

This publication marks a significant contribution to the global scientific community, showcasing our latest advancements in vaccine clinical trials.

Read the full manuscript here: https://www.thelancet.com/journals/lanmic/article/PIIS2666-5247(23)00324-5/fulltext

Furthermore, anticipate the inclusion of our work in the upcoming issue of The Lancet Microbe, set to go live on February 28.

Join us in recognizing this important milestone in scientific research  and stay updated for more developments.

#VisMederi #TheLancetMicrobe #VaccineResearch #SARSCoV2 #ScienceInnovation

********

Il nostro manoscritto CEPI Centralized Laboratory Network: a qualification analysis è stato pubblicato su The Lancet Microbe Online.

Questa pubblicazione rappresenta un contributo significativo alla comunità scientifica globale, mostrando i nostri ultimi progressi nei trial clinici dei vaccini.

Leggi il manoscritto completo qui: https://www.thelancet.com/journals/lanmic/article/PIIS2666-5247(23)00324-5/fulltext

#VisMederiGroup #RicercaVaccini #InnovazioneScientifica
Load more